International Canine Semen Ban

Canine reproductive science sits at a remarkable intersection of biological preservation, elite animal breeding, and specialized veterinary medicine — an intersection that very few franchise concepts have occupied for more than half a century. The International Canine Semen Ban, operating under the broader International Canine Semen Bank (ICSB) brand network, addresses a precise and irreplaceable problem for serious dog breeders: the preservation of irreplaceable genetic material from high-value dogs across time, geography, and even death. Founded in 1971 in Oregon by Carrol C. Platz Jr., a professor who pioneered the freezing and chilling techniques for canine semen that are now industry-standard, ICSB became the first organization to achieve and register litters born from frozen canine semen with the American Kennel Club, the American Dog Field Association, and the National Association of the Greyhound. That 1971 founding date means this organization has been operating continuously for more than 53 years, a longevity that is extraordinarily rare in any franchise category and speaks to the structural durability of the service it provides. The main office remains in Gladstone, Oregon, and the broader ICSB network has grown to more than 40 licensed centers operating in 28 different countries, spanning continents from North America to Europe, Asia, and the Pacific. Within the United States alone, ICSB operates centers in states including Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, Ohio, Tennessee, Texas, Virginia, Wisconsin, and Puerto Rico, with international centers established in Australia, Brazil, Canada, Hungary, Japan, South Korea, Poland, Spain, El Salvador, and Trinidad and Tobago. The total addressable market for veterinary artificial insemination services globally was valued at approximately 4.97 billion to 8 billion dollars in 2024 depending on methodology, and even at the conservative midpoint, this represents an enormous commercial opportunity for specialized service providers operating in the canine reproductive segment. For franchise investors, the International Canine Semen Ban franchise opportunity is not a consumer restaurant or retail play — it is a deeply specialized, knowledge-intensive service business with more than five decades of validated brand equity and a global licensed center footprint that demonstrates repeatable market demand across diverse geographies. This analysis is produced independently by PeerSense and is not sponsored or reviewed by ICSB or any affiliated entity.

The veterinary artificial insemination market is one of the most consistently growing segments within animal health services, and understanding its structure is essential for any investor evaluating the International Canine Semen Ban franchise opportunity. Market valuations from multiple research methodologies place the global veterinary AI market between 4.74 billion and 8 billion dollars in 2023 and 2024, with projections ranging from 8.1 billion dollars by 2033 at a compound annual growth rate of 5.58 percent, to as high as 13 billion dollars by 2032 at a CAGR of nearly 7 percent, and one methodology projects 12.7 billion dollars by 2034 at a CAGR of 8 percent. North America is the dominant regional market, commanding a 31.65 percent revenue share in 2024, driven by a well-developed animal husbandry infrastructure, high per-capita pet ownership, and strong AKC-registered breeder activity that directly feeds demand for canine semen collection, storage, and insemination services. Asia Pacific is the fastest-growing regional market, with India projected to register the highest CAGR from 2025 to 2030, and countries like Japan and South Korea — where ICSB already operates licensed centers — positioned at the vanguard of that expansion. The services segment of the veterinary AI market, which most closely aligns with what an ICSB licensed center provides, generated 3.407 billion dollars in revenue in 2024 and is projected to register the highest growth rate among all market segments through the forecast period. Consumer trends driving this market include rising demand for genetic improvement in purebred dogs, growing awareness of reproductive technology among elite breeders, and the expanding use of AI techniques for the preservation of endangered species — ICSB itself has worked with white-tailed deer, Canadian grey wolf, African lion, red wolf, and various reptile and primate species. Global meat demand, a secondary driver for the broader livestock AI market, is projected to grow by 1.4 percent annually, requiring an additional 3.4 million tons of meat by 2031, which sustains the cattle and swine AI market that runs parallel to the canine segment. The competitive landscape within canine-specific reproductive services remains highly fragmented, with ICSB representing the only globally licensed network of canine semen banking centers, giving it a structural positioning advantage that no regional or independent competitor currently matches at comparable scale.

The International Canine Semen Ban franchise investment profile is one of the more unusual structures in the franchise universe, and transparency requires acknowledging what is and is not known with precision. Specific franchise fee figures, royalty rates, advertising fund contributions, total investment ranges, liquid capital requirements, and net worth thresholds are not published in materials currently available in the public domain for this franchise system. What is documented through publicly available pricing from individual ICSB centers provides a window into the service fee economics: ICSB Oregon, for example, charges a fee of 146 dollars when a semen sample does not meet freezing requirements, and applies a 40 percent discount on the Collection and Processing Fee if the semen does not meet requirements for storing a breeding unit after processing. These granular service-level fees, while modest individually, aggregate across a client base of active breeders to form the revenue foundation of a center-level operation. For comparative context, the broader equine frozen semen market — a related service vertical — shows a single-breeding-season chilled semen fee of 812 dollars per mare at Nebraska Equine Veterinary Clinic, inclusive of all heat cycles, rectal palpations, reproductive ultrasounds, artificial inseminations, and frozen semen storage and handling, with daily mare boarding at 37.61 dollars and vaccination protocols adding 132.28 dollars or more. These figures illustrate the premium pricing power that specialized reproductive services command across animal categories. Each ICSB licensed center operates independently with respect to its billing structure, client base, and facility setup, meaning that investment requirements and revenue potential will vary substantially based on local market size, the operator's existing veterinary or breeding infrastructure, and geographic positioning. Because specific financial disclosures are not currently available, investors evaluating the International Canine Semen Ban franchise cost and investment profile should request a current Franchise Disclosure Document directly from ICSB's main office in Gladstone, Oregon, and seek independent legal and financial counsel before making any commitment. The 40-plus-center global footprint, built over more than five decades, suggests that the licensing model has proven financially viable across a diverse range of market conditions, but independent verification of unit economics is the appropriate next step for serious investors.

The operating model of an International Canine Semen Ban licensed center is fundamentally distinct from consumer-facing franchise formats like food service or retail. Each center functions as an independent specialized veterinary or animal reproduction service provider, with daily operations centered on semen collection, processing, evaluation, freezing via cryopreservation, long-term storage in liquid nitrogen tanks, and artificial insemination services for canine clients. Staffing at ICSB-New Jersey, for example, includes lead reproduction technicians who are in the process of being certified in semen handling, freezing, and storage specifically through the International Canine Semen Bank's certification program, alongside a lead reproductive veterinarian who has received advanced training from Minitube USA in Transcervical insemination, MAVIC insemination, and breeding timing technology. This staffing model — combining a licensed veterinarian with certified reproduction technicians — represents a credentialed, specialized labor structure that differs fundamentally from the low-skill-labor models common in food or retail franchising. The training pathway is formalized through ICSB's certification program for semen handling and storage, ensuring that techniques developed by founder Carrol Platz and refined over 53 years are transmitted consistently across the global network. The format is location-based and equipment-intensive, requiring the proper liquid nitrogen storage infrastructure and cryopreservation equipment — a lesson made critically tangible by the 2018 class-action lawsuit filed against a separate Ohio-based canine semen bank that allegedly failed to maintain adequate liquid nitrogen levels, resulting in the total destruction of client semen specimens. The specialized shipping infrastructure ICSB has developed — including proprietary kits for chilled and frozen semen transport — extends each center's effective service radius beyond its immediate geography and enables international client relationships. The main office in Oregon provides the overarching technical standards and brand framework, while licensed center operators maintain autonomy over local client relationships, pricing structures, and facility management.

Item 19 financial performance data is not disclosed in the current Franchise Disclosure Document for the International Canine Semen Ban franchise. This is a significant data gap for investors conducting rigorous due diligence, and it is worth understanding both what this means and what alternative signals are available. Under FTC franchise disclosure rules, franchisors are not legally required to include Item 19 financial performance representations in their FDD, but if they choose to make any earnings claims, those claims must appear in Item 19 and be supported by documented historical performance data. The absence of Item 19 disclosure means that ICSB cannot legally provide verbal earnings estimates either, and any representations made outside the FDD would constitute a regulatory violation. Looking at industry benchmarks to establish context, the veterinary AI services segment generated 3.407 billion dollars in 2024 across the global market, a figure that, distributed across the estimated thousands of service providers in this space, implies meaningful per-unit revenue potential for specialized operators with established client bases. The ICSB network's documented achievement of producing four beagle puppies in 2010 using semen frozen 38 years prior, five puppies in 2022 from 36-year-old semen, 11 puppies from 35-year-old semen, and 8 puppies from 19-year-old semen bred in Germany demonstrates a technical track record that commands premium positioning and supports premium service fees relative to general veterinary practices offering basic reproductive services. The ongoing storage revenue model — where breeders pay to maintain frozen semen inventory indefinitely — creates a recurring revenue component that is structurally different from transactional service businesses and theoretically supports more predictable cash flow over time. The FPI Score assigned to the International Canine Semen Ban franchise by PeerSense is 38, categorized as Fair, which investors should weigh alongside the absence of Item 19 data when calibrating their risk assessment. Payback period analysis is not calculable from currently available data, reinforcing the importance of requesting detailed financial information directly from ICSB before advancing in the evaluation process.

The International Canine Semen Ban franchise has demonstrated a clear and documentable growth trajectory across its more than 53-year operating history, expanding from a single pioneering laboratory in Oregon in 1971 to a network of more than 40 licensed centers in 28 countries as of current data. The establishment of ICSB-Wisconsin in 2002 by Dr. Marty Greer provides a concrete data point illustrating the ongoing pace of new center establishment, and the presence of centers in technologically sophisticated markets like Japan and South Korea — alongside emerging markets like Brazil and El Salvador — demonstrates the model's adaptability across regulatory and cultural environments. The competitive moat that ICSB has built over five decades is multi-layered: it holds the distinction of being the first organization to achieve AKC-registered litters from frozen canine semen, a historical achievement that established its technical credibility with the elite breeder community and continues to drive referral-based client acquisition. The organization's unique capability to extract viable semen from recently deceased dogs — a technique that addresses one of the most emotionally urgent and time-sensitive needs in the breeding community — represents a proprietary service differentiation that competitors without decades of technique development cannot easily replicate. ICSB's extension into feline semen and the preservation of critically endangered wild species, including African lion, red wolf, Canadian grey wolf, and primates, in collaboration with conservation organizations, broadens both the brand's reputation and its potential institutional client base beyond the commercial dog breeding market. The services segment of the veterinary AI market is projected to register the highest growth rate among all market segments through the forecast period, and the canine segment specifically benefits from sustained AKC registration volumes and the growing willingness of elite breeders to invest in genetic preservation technology. No major acquisitions or leadership transitions have been reported for ICSB in recent periods, suggesting organizational stability at the main office level — a meaningful indicator given that founder-dependent businesses in specialized technical fields can face succession risk that destabilizes franchised networks.

The ideal candidate for the International Canine Semen Ban franchise opportunity is not a general entrepreneur seeking a passive income vehicle — this is a knowledge-intensive, relationship-driven service business that performs best when operated by individuals with existing veterinary credentials, deep connections within the purebred dog breeding community, or demonstrated backgrounds in animal reproduction science. The model documented at ICSB-New Jersey, where a reproductive veterinarian leads clinical operations and certified technicians handle semen processing, suggests that the most successful licensed center operators likely have existing professional infrastructure — a veterinary practice, a breeding kennel operation, or an animal science academic background — that reduces the cost and time required to establish a credible client base. The geographic distribution of the network, with centers concentrated in states like Texas, New York, North Carolina, Tennessee, and Virginia, alongside international markets in Canada, Australia, Hungary, and Poland, indicates that performance is not constrained to any single demographic profile or market size. Markets with high concentrations of AKC-registered purebred breeders, active show dog communities, and proximity to major dog sport competitions represent the highest-density opportunity territories for new center development. The global 28-country footprint also means that prospective licensees in underserved international markets — where ICSB has not yet established a center — may find particularly low competitive density with established brand recognition among the internationally connected breeder community. Franchise agreement term length data is not currently disclosed in available materials, and prospective licensees should clarify renewal, transfer, and resale terms directly with the ICSB main office in Gladstone, Oregon, as part of the formal discovery process.

Any serious investor evaluating the International Canine Semen Ban franchise must approach this opportunity with the analytical discipline that a specialized, niche service business demands. The investment thesis here is built on durable structural advantages: a 53-year operating history, a globally recognized brand that holds documented firsts in AKC-registered frozen semen litters, a services-segment veterinary AI market projected to reach between 8.1 billion and 13 billion dollars by 2032 to 2033, and a recurring revenue component from long-term semen storage that few service franchises can replicate. The risks that require rigorous investigation include the absence of Item 19 financial performance disclosure, the specialized labor requirements that constrain the candidate pool, the critical importance of proper liquid nitrogen storage management as illustrated by the 2018 Ohio lawsuit against an unrelated semen bank, and the FPI Score of 38 that PeerSense has assigned to this franchise — a Fair rating that warrants deeper investigation rather than dismissal. PeerSense provides exclusive due diligence data including SBA lending history, FPI score, location maps with Google ratings, FDD financial data, and side-by-side comparison tools that allow investors to benchmark the International Canine Semen Ban franchise against comparable opportunities in the support activities for animal production category. The combination of a fragmented competitive landscape, a globally proven licensing model, growing consumer and institutional demand for canine reproductive services, and a technical knowledge base that took decades to develop creates a profile that merits serious attention from qualified investors with the right background. Explore the complete International Canine Semen Ban franchise profile on PeerSense to access the full suite of independent franchise intelligence data.